Clinical trial
Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in…
NCT00408512 · Federico II University, Other · Completed
Key facts
| NCT number | NCT00408512 |
|---|---|
| Title | Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study |
| Official title | Increasing Stay-on-therapy in Hypertensive Patients Treated With First-line Diuretics: An Active Pharmacosurveillance and Pharmacogenetic Study. |
| Acronym | stayondiur |
| Lead sponsor | Federico II University, Other |
| Collaborators | Agenzia Italiana del Farmaco |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug, Procedure |
| Interventions | thiazides, Non thiazidic treatment |
| Enrollment | 2,500 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Dec 7, 2006 |
| Last update posted | Jun 27, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: